Encapsulating your ideas


SyVento BioTech is a biotechnology company offering comprehensive services in the development of lipid-based nanocarriers and LNP technology. We specialize in the development of lipid-based formulations for pharmaceutical products, including RNA-based drug products.

Our platform solutions enable the efficient design and implementation of projects to encapsulate and deliver therapeutic molecules, such as small molecules, RNA, DNA, and proteins.


Genetic platform

SyVento BioTech’s R&D Team offers technical and scientific support throughout the entire process, including advice on troubleshooting and optimization of RNA synthesis conditions. Our RNA synthesis proficiency guarantees successful results in downstream applications.

By incorporating these important features, our genetic platform for RNA synthesis
provides:

  • high-quality
  • reliablility
  • cost-effectivness

Delivery platform

Our Team’s qualifications and experience provide a wealth of expertise in the development of lipid-based delivery systems.

SyVento BioTech’s LNP delivery systems:

  • help overcome the challenges of delivering fragile and easily degraded RNA molecules
  • improve the efficacy of mRNA based drugs
  • are designed and optimized to achieve specific drug delivery goals
  • their modularity allows for precise control over the size, surface charge, and composition

Manufacturing platform

Our capabilities offer the possibility of scaling the production of formulations based on lipid nanocarriers by transferring solutions developed in the laboratory on a semi-technical and technical scale.

Thanks to the extensive equipment base, we are able to perform:

  • up-scaling starting from very small batches (from lab scale to pilot & demo scale) and up to 50L batches
  • vials filling: 2000-3000 vials per hour (FnF) of continuous filling

Drug development expertise

Our analytical services have been tailored to assist our Partners in their development projects, while also being available to support any standalone analytical initiative.

100% of SyVento BioTech Research and Development Team have PhD in  Life science – mainly biotechnology and chemistry.

SyVento BioTech at BIO Korea 2025

April 28, 2025

SyVento BioTech at BIO Korea 2025

We are excited to announce that SyVento BioTech will be participating in BIO Korea 2025, one of Asia’s premier biotechnology and pharmaceutical events, taking place 7–9 May in Seoul. Our company will be proudly represented by Eliza Milewicz, Member of the Supervisory Board, who will be engaging in one-on-one partnering meetings, exploring collaborative opportunities, and […]

Let’s meet at World Vaccine Congress!

April 9, 2025

Let’s meet at World Vaccine Congress!

We are excited to announce that SyVento BioTech will be attending the World Vaccine Congress in Washington, D.C. from April 22-24, 2025! This premier event brings together industry leaders to discuss groundbreaking advancements in vaccine development across infectious diseases, cancer immunotherapy, veterinary vaccines, and more. SyVento BioTech is committed to advancing vaccine technologies and biopharmaceutical […]

Join us at LNP Summit in Boston!

April 7, 2025

Join us at LNP Summit in Boston!

SyVento BioTech is proud to announce our participation in the 4th LNP Formulation & Process Development Summit in Boston– the premier global forum dedicated exclusively to Lipid Nanoparticle (LNP) innovation! As a company at the forefront of advanced drug delivery technologies, we cannot miss the opportunity to attend this significant event. SyVento BioTech specializes in […]

SyVento BioTech at CDMO Live 2025!

April 1, 2025

SyVento BioTech at CDMO Live 2025!

We are thrilled to share that SyVento BioTech will be a Silver Partner at CDMO Live this year. This is a fantastic event organized by Pharma Source that provides a unique platform to engage with industry expert, exchange insights, and present the innovative solutions shaping the future of science. We look forward to showcasing our […]

Let’s meet at Pharm Connect in Budapest!

March 28, 2025

Let’s meet at Pharm Connect in Budapest!

Pharm Connect Congress is the perfect place to connect with leaders from the pharmaceutical and biotech industries, exchange insights, and explore groundbreaking innovations. This year, SyVento BioTech will be there, represented by Maciej Boruczkowski, who is eager to discuss new opportunities, cutting-edge solutions, and potential collaborations.

SyVento BioTech at CE BioForum 2025

March 14, 2025

SyVento BioTech at CE BioForum 2025

We are excited to announce that SyVento BioTech will be participating in Central European BioForum 2025, the premier event for the biotechnology sector in Central Europe, taking place on 2-3 April 2025 in Warsaw. At CE BioForum, SyVento BioTech will be actively involved in expert-led panel discussions. Our representatives, @Tomasz Piec and @Dominik Lipka, will […]

Dominik Lipka will be a speaker at RNA Leaders!

February 26, 2025

Dominik Lipka will be a speaker at RNA Leaders!

We are excited to announce that our CTO, Dominik Lipka, will be speaking at RNA Leaders. Do not miss his presentation: Innovations and Challenges in LNP-based RNA Therapeutics Development and Manufacturing which will take place on 6 March during mRNA Therapeutics & Vaccines: Pre-Clinical & Clinical Advancements stream. Our Team will be waiting for you […]

SyVento BioTech at BIO-Europe Spring in Milan!

February 24, 2025

SyVento BioTech at BIO-Europe Spring in Milan!

We are thrilled to share that SyVento BioTech will attend the BIO-Europe Spring which will take place on 17-19 March in Milan! This premier event is a fantastic opportunity to connect with industry leaders, explore new collaborations, and stay at the forefront of biotech innovation. We look forward to engaging discussions, exchanging insights, and discovering […]

Meet the SyVento BioTech Team at RNA Leaders!

February 21, 2025

Meet the SyVento BioTech Team at RNA Leaders!

Let’s connect and discuss the future of RNA therapeutics with you. Visit us at booth #15 to meet our representatives: Tomasz Piec, Dominik Lipka PhD Eng., Monika Wisniewska-Usielskaand Filip Zdrodowski. It is a great chance to talk about next-gen RNA, mRNA vaccines, and groundbreaking therapeutics. We look forward to exchanging insights and exploring new collaboration […]

Contact Us


Let's collaborate and create quality liposome encapsulated drugs together.

    This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.